Previous 10 | Next 10 |
BD Names Dr. Joseph M. Smith as Chief Scientific Officer Digital Health Pioneer to Focus on External Innovation; Becomes Co-Chair of BD Scientific Advisory Board PR Newswire FRANKLIN LAKES, N.J. , Nov. 29, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Compan...
We explain why selling the cash-covered puts and covered calls is a safer choice and earns a high income. We will discuss how to formulate an options income strategy that's sustainable and repeatable. In this monthly series, we present how to go about selecting the right kind of s...
BD Names Francesca DeMartino as Senior Vice President of Investor Relations PR Newswire FRANKLIN LAKES, N.J. , Nov. 24, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced France...
Generation Investment Management’s 13F portfolio value decreased from $24.11B to $24.05B this quarter. They increased Alibaba Group Holding, Intel, MercadoLibre, and Huazhu Group while reducing Cisco Systems, Equifax, Texas Instruments and Cognizant. The top three positions...
Becton, Dickinson is one of the most stable predictable low-volatility health care stocks out there. It sells essential tools and instruments necessary for all sorts of modern medicine, making it a reliable way to invest in the aging population trend. Shares are near a 10-year low...
Investors saw a few very good dividend increases in the first half of November, with ADP, Snap-on, and Roper Technologies announcing double-digit boosts, and a massive 29% boost from HP. The second half of November will bring double-digit boosts from a few more companies including Nik...
Ahead of its Investor Day Becton, Dickinson (BDX -0.4%) laid out its plans with a goal of achieving a long-term compound annual revenue growth of 5.5% or more. The medical devices maker also expects to leverage its margins to accomplish a double-digit EPS growth with a consistent increase in ...
BD to Highlight Progress Against BD 2025 Strategy and Plans for Long-Term Growth - Innovation agenda focuses on advancing human health through smart connected care, new care settings and chronic disease outcomes - Targets long-term revenue growth of 5.5%+ and double-digit EP...
In this article series, we provide a weekly summary of dividend changes. A summary table presents relevant data and key statistics of dividend increases. We highlight one of the stocks and present performance, valuation, and earnings charts. For further details see: Divi...
VANCOUVER – BIOTECH INSIDER - New at-home Covid tests are on the way, according to the Biden administration, which announced a new $70 million plan to speed up authorization, especially in the wake of a shortage . A study from Kaiser showed t...
News, Short Squeeze, Breakout and More Instantly...
Becton Dickinson and Company Company Name:
BDX Stock Symbol:
NYSE Market:
Becton Dickinson and Company Website:
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases PR Newswire Collaboration on Flow Cytometry-Based Companion Diagnostics to Advance Personalized Health Care FRANKLIN LAKES, N.J. and SECAUCUS, N.J. , July 25, 20...
2024-07-11 12:00:00 ET July 11, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the second of a two-part series looking at recent news and developments in the blood infections treatment market, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:C...
BD Statement on Supplier Issue Impacting BD BACTEC™ Blood Culture Vials PR Newswire Company Committed to Support Global Health and Customers BD Taking all Available Measures to Mitigate Supplier Issue FRANKLIN LAKES, N.J. , July 10 , 2024...